Top Markets
#1 Official Trump Official Trump +29.26%
#2 Siacoin Siacoin +23.15%
#3 EXOD EXOD +18.93%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.26%
#5 MowCat MowCat +17.88%
#6 Melania Meme Melania Meme +17.73%
#7 Wrapped POL Wrapped POL +15.83%
#8 POL (ex-MATIC) POL (ex-MATIC) +15.50%
#9 Siren Siren +15.47%
#10 Unit Pump Unit Pump +15.05%
Coin of the day
Official Trump Official Trump
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Classifica tra le azioni #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Prezzo delle azioni
$4.00
Ultima sincronizzazione: 2026-08-20
Capitalizzazione di mercato
$75.37M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
12.99%
Paese
US
Scambia RetinalGenix Technologies Inc. (RTGN)

Categoria

Healthcare
Utile per RetinalGenix Technologies Inc. (RTGN)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di RetinalGenix Technologies Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di RetinalGenix Technologies Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
- -
DE